Related Experiment Video
Updated: Oct 14, 2025

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
The Impact of COVID-19 on Liver Injury
Dr Reham M Dawood1, Ghada Maher Salum1, Mai Abd El-Meguid1
1Department of Microbial Biotechnology, Genetic Engineering Division, National Research Centre, Giza, Egypt.
Insights
COVID-19 can cause liver injury, impacting disease severity and predicting acute respiratory distress syndrome (ARDS). This review covers COVID-19 liver injury causes and management strategies.
Area of Science:
- Medicine
- Virology
- Hepatology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, is a significant global health crisis.
- Lung injury leading to ARDS is a primary cause of mortality in COVID-19 patients.
- Liver injury and dysfunction are frequently reported in COVID-19 patients, correlating with disease severity.
Purpose of the Study:
- To review the epidemiological features of liver injury in COVID-19.
- To explore the potential causes of hepatic injury in the context of SARS-CoV-2 infection.
- To discuss management and prevention strategies for liver injury in COVID-19 patients.
Main Methods:
- This review synthesizes current literature on COVID-19 and liver injury.
- It examines direct viral effects, inflammatory responses, and drug-induced liver injury.
- Pre-existing liver conditions and hypoxemia as contributing factors are also considered.
Main Results:
- Liver injury in COVID-19 can stem from direct SARS-CoV-2 effects, systemic inflammation, hypoxemia, and antiviral medications.
- The presence and severity of liver dysfunction may serve as a prognostic indicator for ARDS development.
- Pre-existing liver diseases can exacerbate COVID-19-related hepatic complications.
Conclusions:
- Understanding the multifaceted causes of liver injury in COVID-19 is crucial for patient management.
- Proactive monitoring and tailored strategies are necessary to prevent and treat hepatic complications.
- This review provides a comprehensive overview to guide clinical practice and future research.
Abstract:
The current coronavirus disease outbreak of 2019 (COVID-19) has led to a global pandemic. The principal cause of mortality in COVID-19 is represented lung injury with the development of acute respiratory distress syndrome (ARDS). In patients with COVID-19 infection, liver injury or liver dysfunction has been reported. It may be associated with the general severity of the disease and serve as a prognostic factor for ARDS development. In COVID-19, the spectrum of liver damage may range from direct SARS-CoV-2 viral proteins, inflammatory processes, hypoxemia, the antiviral drugs induced hepatic injury and the presence of the preexisting liver disease. We highlight in this review important topics such as the epidemiological features, potential causes of liver injury, and the strategies for management and prevention of hepatic injury in COVID-19 patients.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

